Newborn Gut Microbiome Predicts Later Allergy and Asthma, Study Finds
Gut microbes present in some one-month-old infants predict a three-fold higher risk of developing allergic reactions by age two and asthma by age four.
University of California San Francisco
Give to UCSF
Immune-Cell Population Predicts Immunotherapy Response in Melanoma
The abundance of a subtype of white blood cells in melanoma tumors can predict whether or not patients will respond to a form of cancer immunotherapy known as checkpoint blockade, according to a new study led by UCSF researchers and physicians.
Gut Bacteria Linked to Rare Autoimmune Disease
A new study led by UCSF scientists shows that a bacterium commonly found in the human gut is overrepresented in patients with a rare, often disabling autoimmune disease known as neuromyelitis optica.
Researchers Map Zika’s Routes to the Developing Fetus
Zika virus can infect numerous cell types in the human placenta and amniotic sac, according to researchers at UCSF and UC Berkeley who show in a new paper how the virus travels from a pregnant woman to her fetus.
Go-Between Immune Cell is Key to Priming the Body’s Fight Against Cancer
Using advanced imaging technology that allowed them to spy on interactions among cells in the lymph nodes of living mice, a research team led by UCSF scientists has identified a cell that is a key player in mounting the immune system’s defense against cancer.
Covert Inflammation May Trigger Many Forms of Cancer
A previously unidentifiable type of low-grade inflammation may explain why common anti-inflammatory drugs such as aspirin have shown promise against some types of cancer – even when patients don’t display typical signs of inflammation.
UCSF Researchers Reappraise Treatment for Belly Birth Defect
UC San Francisco researchers have shed light on how the immune system of a fetus can run amok, triggering inflammation in the developing intestines that protrude outside of the body through a hole beside the belly button.
Wrapping Up Multiple Sclerosis
With one drug to shut down its progression and another to undo its damage, plus a worldwide effort stalking the origins of multiple sclerosis, MS doesn’t stand a chance.
UCSF Immunologist to Head New Parker Institute for Cancer Immunotherapy
Renowned UCSF immunologist Jeffrey Bluestone, PhD, has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, established by Silicon Valley entrepreneur Sean Parker.
New Cancer Immunotherapy Clinic Offers Unique Studies of Promising Treatments
Oncologist Lawrence Fong is leading UCSF’s newly launched Cancer Immunotherapy Program, a clinic and laboratory dedicated to developing and studying cutting-edge immunotherapy treatments.
Berger, Bluestone Named to White House Cancer Moonshot Expert Panel
Mitchel Berger and Jeff Bluestone have been named to a Blue Ribbon Panel of scientific experts, cancer leaders and patient advocates that will help to guide the National Cancer Moonshot Initiative.
Cancer Center Awards First ‘Impact Grants’ for High-Risk, High-Reward Projects
Eleni Linos and Stephen Francis have been awarded the first UCSF Cancer Center Impact Grants, to pursue high-risk, high-reward research projects that would’ve been unlikely to be funded through conventional mechanisms.
UCSF Research Suggests New Model for Cancer Metastasis
Scientists at UC San Francisco have been able to directly observe, for the first time, how invasive cancer cells create a beachhead as they migrate to the lung in a mouse model of metastatic cancer.
